Bar Harbor, ME and Berkeley, CA — Caribou Biosciences, Inc. and The Jackson Laboratory (JAX) announced an agreement today whereby Caribou has granted JAX non-exclusive worldwide rights to use its CRISPR-Cas9 intellectual property to create genetically engineered mice for research purposes. Caribou’s market-leading CRISPR-Cas9 technology accurately targets and cuts DNA to produce precise and controllable […]
Biologist Scott Lowe Recognized for Contributions to Next-Generation Tools SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Dr. Scott Lowe has received an Agilent Thought Leader Award in recognition for his contributions to the identification of key genes – including those that promote or suppress cancer – and their characterization as therapeutic […]
The University has signed a licence agreement with life sciences giant Merck for pioneering fluorescent probe technology that helps understand how disease progresses. Edinburgh Research & Innovation (ERI), the commercialisation arm of The University of Edinburgh, has entered into a licence agreement with the life science business of Merck, a leading science and technology company […]
SAN DIEGO, CA. — Molecular Assemblies Inc., a company developing a proprietary enzymatic DNA synthesis technology designed to power the next generation of DNAbased products, today announced the appointment of Michael J. Kamdar as CEO and director. Mr. Kamdar brings 25 years of highly successful biotechnology leadership and transaction experience to his new role. On […]
SureGuide Offerings Include GeCKO Libraries and Full Customization for Any CRISPR Screening Experiment SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today launched a comprehensive offering of pooled CRISPR libraries for functional genomics. SureGuide harnesses Agilent’s industry-leading oligonucleotide synthesis platform to create CRISPR guide libraries, which are a critical component of the CRISPR/Cas genome editing […]
Series B Funding Round Totals $45 Million from Syndicate of Life Sciences and Technology Investors BOSTON, Mass. – Emulate, Inc. today announced that it has expanded its Series B financing with an additional $17 million in equity funding, bringing the total amount raised in the Series B round to $45 million. The expanded funding from […]
Collaborative R&D to focus on innovation for patient-driven advances in cancer treatment ‘Human Emulation System’ offers a living platform to understand disease and design new cancer medicines BOSTON, Mass. – Emulate, Inc. announced today its strategic collaboration with the Lawrence J. Ellison Institute for Transformative Medicine of USC to use Emulate’s Organs-on-Chips technology to conduct […]
FormaPure DNA is a High-Quality, Scalable Extraction Kit Optimized for Automation INDIANAPOLIS, IND. – Today, at the American Society of Human Genetics Annual Meeting in Vancouver, Beckman Coulter Life Sciences launched FormaPure DNA, the newest addition to its growing portfolio of nucleic acid isolation, clean up and purification reagent kits. FormaPure DNA is a high-quality, […]
Joint capabilities seek to establish Organs-on-Chips as a new preclinical testing platform BOSTON, Mass. – Emulate, Inc. announced today a strategic collaboration with Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) that seeks to integrate Emulate’s Organs-on-Chips technology into preclinical drug evaluation and testing services. Emulate’s proprietary technology attempts to recreate the natural physiology of […]
Combined expertise will create best-in-class assay systems for drug potency, stability testing and other applications MANASSAS, Va. and DURHAM, N.C. — ATCC, a global leader in biological materials development, management and standards, and BioAgilytix, a leading provider of contract testing services with a specialization in biologics, today announced a strategic partnership to develop new and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
